Effect of Hemolysis Regarding the Characterization and Prognostic Relevance of Neuron Specific Enolase (NSE) after Cardiopulmonary Resuscitation with Extracorporeal Circulation (eCPR)

Background: Hemolysis, a common adverse event associated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO), may affect neuron-specific enolase (NSE) levels and potentially confound its prognostic value in predicting neurological outcomes in resuscitated patients without return of spontaneous circulation (ROSC) that require extracorporeal cardiopulmonary resuscitation (eCPR). Therefore, a better understanding of the relationship between hemolysis and NSE levels could help to improve the accuracy of NSE as a prognostic marker in this patient population. Methods: We retrospectively analyzed the records of patients who received a VA-ECMO for eCPR between 2004 and 2021 and were treated in the medical intensive care unit (ICU) of the University Hospital Jena. The outcome was measured clinically by using the Cerebral Performance Category Scale (CPC) four weeks after eCPR. The serum concentration of NSE (baseline until 96 h) was analyzed by enzyme-linked immunosorbent assay (ELISA). To evaluate the ability of individual NSE measurements to discriminate, receiver operating characteristic (ROC) curves were calculated. Serum-free hemoglobin (fHb, baseline until 96 h) served as a marker for identifying a confounding effect of parallel hemolysis. Results: 190 patients were included in our study. A total of 86.8% died within 4 weeks after ICU admission or remained unconscious (CPC 3–5), and 13.2% survived with a residual mild to moderate neurological deficit (CPC 1–2). Starting 24h after CPR, NSE was significantly lower and continued to decrease in patients with CPC 1–2 compared to the group with an unfavorable outcome of CPC 3–5. In addition, when evaluating on the basis of receiver operating characteristic curves (ROC), relevant and stable area under the curve (AUC) values for NSE could be calculated (48 h: 0.85 // 72 h: 0.84 // 96 h: 0.80; p < 0.01), and on the basis of a binary logistic regression model, relevant odds ratios for the NSE values were found even after adjusting for fHb regarding the prediction of an unfavorable outcome of CPC 3–5. The respective adjusted AUCs of the combined predictive probabilities were significant (48 h: 0.79 // 72 h: 0.76 // 96 h: 0.72; p ≤ 0.05). Conclusions: Our study confirms NSE as a reliable prognostic marker for poor neurological outcomes in resuscitated patients receiving VA-ECMO therapy. Furthermore, our results demonstrate that potential hemolysis during VA-ECMO does not significantly impact NSE’s prognostic value. These findings are crucial for clinical decision making and prognostic assessment in this patient population.

[1]  A. Rossetti,et al.  Neuroprognostication Under ECMO After Cardiac Arrest: Are Classical Tools Still Performant? , 2022, Neurocritical Care.

[2]  S. Hunziker,et al.  Neuron-Specific Enolase (NSE) Predicts Long-Term Mortality in Adult Patients after Cardiac Arrest: Results from a Prospective Trial , 2021, Medicines.

[3]  K. Werdan,et al.  Einfluss des therapeutischen Temperaturmanagements auf den klinischen Verlauf bei intrahospital reanimierten Patienten , 2021, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[4]  J. Soar,et al.  European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care , 2021, Intensive Care Medicine.

[5]  J. Timsit,et al.  Neuron-Specific Enolase Levels in Adults Under Venoarterial Extracorporeal Membrane Oxygenation , 2020, Critical care explorations.

[6]  K. Werdan,et al.  [Relationship between body temperature, neuron-specific enolase, and clinical course in patients after out-of-hospital cardiac arrest]. , 2020, Medizinische Klinik, Intensivmedizin und Notfallmedizin.

[7]  S. Blankenberg,et al.  Neuron-specific-enolase as a predictor of the neurologic outcome after cardiopulmonary resuscitation in patients on ECMO. , 2019, Resuscitation.

[8]  C. Schmid,et al.  NSE serum levels in extracorporeal life support patients-Relevance for neurological outcome? , 2017, Resuscitation.

[9]  B. Abella,et al.  Inter-rater reliability of post-arrest cerebral performance category (CPC) scores. , 2015, Resuscitation.

[10]  F. Beyersdorf,et al.  Neuron-specific enolase correlates to laboratory markers of haemolysis in patients on long-term circulatory support. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[11]  M. Wise,et al.  Neuron-Speci fi c Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33 C and 36 C , 2015 .

[12]  O. Etard,et al.  Serum neuron-specific enolase as predictor of outcome in comatose cardiac-arrest survivors: a prospective cohort study , 2011, BMC cardiovascular disorders.

[13]  A. Rossetti,et al.  Predicting neurological outcome after cardiac arrest , 2011, Current opinion in critical care.

[14]  H. Viertiö-Oja,et al.  Hypothermia-treated cardiac arrest patients with good neurological outcome differ early in quantitative variables of EEG suppression and epileptiform activity* , 2009, Critical care medicine.

[15]  F. Nomura,et al.  Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation. , 2009, Resuscitation.

[16]  T. Cronberg,et al.  Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia. , 2009, Resuscitation.

[17]  P. Siostrzonek,et al.  Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase. , 2006, European heart journal.

[18]  S. Vieira,et al.  Serum neuron-specific enolase as early predictor of outcome after in-hospital cardiac arrest: a cohort study , 2006, Critical care.

[19]  G. B. Young,et al.  Practice Parameter: Prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review) , 2006, Neurology.

[20]  H. Sigusch,et al.  Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale. , 2005, Resuscitation.

[21]  V. Pettilä,et al.  Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With Hypothermia , 2003, Stroke.

[22]  C. Alling,et al.  Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. , 2000, The Annals of thoracic surgery.

[23]  D. Krieger,et al.  Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. , 1997, Critical care medicine.

[24]  F. Goodwin,et al.  Brain endolases as specific markers of neuronal and glial cells. , 1978, Science.

[25]  D. Schmechel,et al.  Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. , 1987, Annual review of neuroscience.